Medicare Enrolled
Dr. Anand Saranathan, M.D.
Optician · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saranathan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saranathan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saranathan
Dr. Anand Saranathan is an optician specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Saranathan performed 8,782 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Saranathan received a total of $109,908 from 47 pharmaceutical and/or device companies across 670 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saranathan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 7% volume in TX
$109,908 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,782
Medicare services
Top 7% in TX for optician
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,632 | $0 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
450 | $62 | $292 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
319 | $0 | $4 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
214 | $34 | $224 |
| Injection, fentanyl citrate, 0.1 mg | 179 | $1 | $12 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
176 | $728 | $4,847 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
151 | $9 | $55 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
99 | $96 | $420 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
73 | $357 | $3,816 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
68 | $1 | $3 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
60 | $99 | $757 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $52 | $399 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
43 | $354 | $2,539 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $102 | $554 |
| Replacement of tunneled central venous tube This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access. |
39 | $350 | $4,316 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
37 | $30 | $206 |
| Balloon dilation of vein, initial vein A procedure to widen a vein using a balloon catheter, with radiologist review. |
36 | $1,107 | $7,523 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
33 | $80 | $547 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $71 | $533 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
18 | $124 | $875 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $140 | $813 |
| Hemodialysis circuit clot removal and vessel dilation This procedure involves removing or dissolving a blood clot within the hemodialysis circuit and using a balloon to widen the dialysis access segment, with imaging review by a radiologist. |
12 | $1,689 | $12,589 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
11 | $482 | $3,242 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
85.1% medium
13.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$109,908
Total received (2018-2024)
Avg $15,701/year across 7 years
Top 3% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
670
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,467
2023
$17,423
2022
$34,348
2021
$9,621
2020
$5,418
2019
$14,710
2018
$7,921
Payments by company (2024)
Amgen Inc.
$18,997
AstraZeneca Pharmaceuticals LP
$374
Ardelyx, Inc.
$182
Bayer Healthcare Pharmaceuticals Inc.
$174
Bard Peripheral Vascular, Inc.
$143
Renalytix AI, Inc.
$102
Lilly USA, LLC
$65
Travere Therapeutics, Inc.
$62
Novartis Pharmaceuticals Corporation
$54
Becton, Dickinson and Company
$53
OPKO Pharmaceuticals, LLC
$47
Philips North America LLC
$46
Aurinia Pharma U.S., Inc.
$46
Mallinckrodt Hospital Products Inc.
$41
Novo Nordisk Inc
$24
ARGON MEDICAL DEVICES, INC.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SCPHARMACEUTICALS INC.
$16
Top 3 companies account for 95.5% of 2024 payments
All-time payments by company (2018-2024) ›
Vifor Pharma, Inc.
$26,166
Relypsa, Inc.
$22,689
Horizon Therapeutics plc
$21,081
Amgen Inc.
$19,202
Bayer HealthCare Pharmaceuticals Inc.
$10,927
Bard Peripheral Vascular, Inc.
$2,385
Keryx Biopharmaceuticals, Inc.
$2,169
AstraZeneca Pharmaceuticals LP
$1,168
Bayer Healthcare Pharmaceuticals Inc.
$476
BARD PERIPHERAL VASCULAR, INC.
$429
Aurinia Pharma U.S., Inc.
$406
Mallinckrodt Hospital Products Inc.
$348
Mallinckrodt Enterprises LLC
$187
Ardelyx, Inc.
$182
OPKO Pharmaceuticals, LLC
$176
Mallinckrodt LLC
$169
Medtronic, Inc.
$160
Otsuka America Pharmaceutical, Inc.
$128
Travere Therapeutics, Inc.
$114
Novartis Pharmaceuticals Corporation
$113
AKEBIA THERAPEUTICS INC
$103
Renalytix AI, Inc.
$102
Philips Electronics North America Corporation
$98
Chiesi USA, Inc.
$95
Lilly USA, LLC
$84
Daiichi Sankyo Inc.
$83
GlaxoSmithKline, LLC.
$76
Horizon Pharma plc
$62
Becton, Dickinson and Company
$53
Philips North America LLC
$46
Calliditas Therapeutics US Inc.
$45
Fresenius USA Marketing, Inc.
$42
Shire North American Group Inc
$38
GENZYME CORPORATION
$37
Abbott Laboratories
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Novo Nordisk Inc
$24
ARGON MEDICAL DEVICES, INC.
$24
Ultragenyx Pharmaceutical Inc.
$22
CALLIDITAS THERAPEUTICS US INC.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
CMP Pharma, Inc.
$19
SCPHARMACEUTICALS INC.
$16
Mozarc Medical US LLC
$16
Tactile Systems Technology Inc
$15
PFIZER INC.
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 63.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8685) OEM Other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ATLAS · AURYXIA · Auryxia · BENLYSTA · CHAMELEON · CLEVIPREX · COVERA · CRYSVITA · Carospir · Chameleon · Clot Management · ELLIPSYS VASCULAR ACCESS SYSTEM · ETERNA · EVUSHELD · Edarbyclor · FABRY-DISEASE · FARXIGA · FLEXITOUCH · FLUENCY · FUROSCIX · Fluency Endovascular Stent Graft · GATTEX · IBSRELA · IMPRA ePTFE Vascular Grafts · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · JARDIANCE · JYNARQUE · KENGREAL · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · Korsuva · LIFESTAR · LOKELMA · LUPKYNIS · LUTONIX · LUTONIX Drug Coated Balloon · MINIMED 770G · NATPARA (PARATHYROID HORMONE) · PREVNAR - 13 · PROCLAIM · Parsabiv · RAYALDEE · Rayaldee · Repatha · Rybelsus · TARPEYO · TAVNEOS · VENASEAL · Velphoro · Veltassa · Venclose Maven Catheter · Venovo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
505
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
WOMANS HOSPITAL OF TEXAS,THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saranathan is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saranathan experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Saranathan performed 6,632 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Saranathan receive payments from pharmaceutical companies?
Yes. Dr. Saranathan received a total of $109,908 from 47 companies across 670 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saranathan's costs compare to other opticians in Houston?
Dr. Saranathan's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saranathan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Houston
Browse opticians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
Vifor Pharma, Inc. Payments to Doctors
See all physicians who received payments from Vifor Pharma, Inc.
By company
Relypsa, Inc. Payments to Doctors
See all physicians who received payments from Relypsa, Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology